UBC Medical Indonesia Tbk. vs Semen Baturaja Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Semen Baturaja Tbk. trades at Rp166 (market cap 1.67T, 2.93M 24h volume). The key difference: Semen Baturaja Tbk. is far larger — about 2.6× UBC Medical Indonesia Tbk.'s market cap, and Semen Baturaja Tbk. is more actively traded (2.93M versus 843K). Which is the better fit depends on your goals.
| LABS | SMBR | |
|---|---|---|
Market Cap | 635.95B | 1.67T |
Volume | 843K | 2.93M |
Lot | 8.43K | 29.25K |
Turnover | 137.6M | 485.3M |
Average Price | 163.22 | 165.91 |
Value | 137.6M | 485.3M |
Indicative Equilibrium Price | 165 | 166 |
Indicative Equilibrium Volume | 246 | 23 |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Semen Baturaja (Persero) Tbk (the Company) was established by Deed of Notary Jony Frederik Berthold Tumbelaka Sinjai No. 34, in Jakarta, dated November 14, 1974, amended by the same notary on November 21, 1974, amended by the same notary on November 21, 1974 Deed No. 49.
Read more on SMBR →